The Drug-Induced Respiratory Disease Website

XI - Pulmonary vasculopathies

XI.i

Pulmonary veno-occlusive disease

1

Evidence level

low

XIV - Pleural involvement

XIV.o

Pleuroparenchymal fibroelastosis (PPFE)

3

Evidence level

probable

XIV.p

Pleuroparenchymal fibroelastosis (PPFE)

2

Evidence level

possible

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

3

Evidence level

probable

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.a

Pneumonitis (ILD)

4

Evidence level

strong

XXIV.b

Pneumonitis (ILD), acute and/or severe (may cause ARDS)

2

Evidence level

possible

XXIV.h

Pulmonary fibrosis (may improve but partly following drug discontinuation)

3

Evidence level

probable

XXXIII - Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)

XXXIII.m

Path: Pulmonary veno-occlusive disease (PVOD)

1

Evidence level

low